Atlas Trials

TP53 Y220C Mutation

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch TP53 Y220C Mutation

RecordFirmDate
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. (NCT07372625)PMV Pharmaceuticals, Inc2026-02-04

Track TP53 Y220C Mutation automatically

Every clearance here is in the API, with alerts when new ones post.